Lv1
25 积分 2021-01-21 加入
Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha–expressing recurrent ovarian cancer: An integrated safety summary
7天前
已完结
Exploiting the folate receptor α in oncology
7天前
已完结
Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma
2个月前
已完结
Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005
2个月前
已完结
Comparison of Worldwide Disease Prevalence and Genetic Prevalence of Inherited Retinal Diseases and Variant Interpretation Considerations
4个月前
已完结
YES1: A Novel Therapeutic Target and Biomarker in Cancer
5个月前
已完结
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
5个月前
已完结
Abstract CT016: Clinical activity of single-agent ZN-c3, an oral WEE1 inhibitor, in a phase 1 dose-escalation trial in patients with advanced solid tumors
5个月前
已关闭
皖公网安备34019202002308
